share_log

HC Wainwright & Co. Reiterates Buy on Aurinia Pharmaceuticals, Maintains $13 Price Target

HC Wainwright & Co. Reiterates Buy on Aurinia Pharmaceuticals, Maintains $13 Price Target

HC Wainwright & Co.重申买入Aurinia Pharmicals,维持13美元的目标股价
Moomoo 24/7 ·  03/01 14:09

HC Wainwright & Co. analyst Ed Arce reiterates Aurinia Pharmaceuticals (NASDAQ:AUPH) with a Buy and maintains $13 price target.

HC Wainwright & Co. 分析师埃德·阿尔塞重申奥里尼亚制药公司(纳斯达克股票代码:AUPH)的买入并维持13美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发